CareDx, Inc (NASDAQ:CDNA) Q4 2022 Earnings Call Transcript

Reginald Seeto: I think living donors is such a huge area as an opportunity. And I think I’ll share a real example for you, Yi Chen. I think how we think of behavior in the community and one of our team members actually his wife was actually needing a transplant and actually put out a post to get an organ and our touristic sense. And during that week, there were probably more than a dozen plus — donors that stepped up and offered to help out during that time. So I do think there is that opportunity. I do think addressing staffing shortages, I think making sure there’s data time. I think now seeing the decline in some of the infectious diseases, which were quite high during Q4 last quarter go away, will be important. But I do think just knowing at least on the artistic side, not including directed donor, that there’s always an incredible opportunity of human behavior that we’re seeing where people are willing to help out in this critical organ space, and we’ve seen it real time in our organization.

Yi Chen: Okay. Thank you.

Operator: We have reached the end of our question-and-answer session. I would like to turn the conference back over to management for closing comments.

Reginald Seeto: Yes. Thanks very much. And we really — 2022 was a year that was difficult. I think 2023 is one where we want to build on the catalyst that we have to build the organization to continue increasing collections as part of the infrastructure we built last year and also to focus on coverage of the 3Cs, as we call them. We think we have an incredible role to play as an organization in the transplant ecosystem. And we certainly thought that obligation not only from physicians, but patients and associations. Everyone looks at CareDx to really play that role and it’s a role that we’ve gladly taken as to be a leader in this space. So I think if you think of anything involving transplant, then we’ll be involved in it. So I want to thank again the CareDx team for working so hard during 2022.

And I also want to thank you the to the analysts for the great questions and also to any shareholders or investors who may be listening in and hopefully supporting this space. It’s such a critical one, and it’s a great one to be in. Thank you again, and have a wonderful evening or afternoon, depending where you are. Thank you.

Operator: Thank you. This does conclude today’s conference. You may disconnect your lines at this time and thank you for your participation.